🇺🇸 Bupivacaine and Fentanyl in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 2
Most-reported reactions
- Acute Generalised Exanthematous Pustulosis — 1 report (50%)
- Drug Reaction With Eosinophilia And Systemic Symptoms — 1 report (50%)
Frequently asked questions
Is Bupivacaine and Fentanyl approved in United States?
Bupivacaine and Fentanyl does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Bupivacaine and Fentanyl in United States?
Bnai Zion Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.